phase ib/ii trial of siremadlin alone or in combination with dli in high-risk aml post-allosct
Published 1 year ago • 101 plays • Length 2:15Download video MP4
Download video MP3
Similar videos
-
2:10
phase ib trial of entinostat in combination with pembrolizumab in r/r mds or aml
-
4:45
phase ib/ii multi-arm study of combinations of novel agents in r/r aml
-
2:41
a phase i/ii study of afm13 in combination with cord blood-derived nk cells in patients with r/r hl
-
2:19
phase i trial of ca-4948 in aml or mds
-
1:54
fusion-aml-001: molecular changes associated with azacitidine & durvalumab in tp53m aml and hr-mds
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:04
introducing a phase ib/ii trial to evaluate tasquinimod for the treatment of myelofibrosis
-
18:55
mixed leukocyte reaction and other antigen-presentation assays [webinar]
-
1:52
implantation of the double c-loop platform with medicel accuject
-
40:57
imin 372 course lecture 2021 [what is flow cytometry?]
-
1:39
phase i/ii trial of adct-602 in b-all
-
58:13
optimising transplant outcome in adults allografted for aml
-
3:46
the impact of cytogenetic risk on outcomes of haploidentical transplantation in r/r aml
-
5:13
phase ii trial of pembrolizumab prior to allo-sct in aml
-
3:28
a phase ib trial of fixed-volume isatuximab infusion in newly-diagnosed multiple myeloma
-
2:44
phase i/ii study of novel flt3 inhibitor hm43239 in r/r aml
-
3:21
a phase i trial of hu8f4, an anti-pr1/hla-a2 monoclonal antibody, in r/r myeloid malignancies
-
1:15
outcomes of non-intensive chemotherapy differ for idh1 and idh2-mutated aml
-
1:13
cytometry versus morphology in the monitoring of aml
-
4:15
phase ib trial of avid200 in refractory myelofibrosis
-
3:15
using targeted therapies to optimize transplant outcomes in aml